We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
uniQure NV | NASDAQ:QURE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.13 | 2.78% | 4.81 | 4.46 | 4.80 | 4.965 | 4.66 | 4.78 | 452,909 | 23:41:32 |
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 02, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE) a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced company presentations at the following conferences taking place in October:
Alliance for Regenerative Medicine (ARM) 2017 Cell & Gene Meeting on the Mesa, October 4 - 6 2017, at the Estancia La Jolla Hotel & Spa in La Jolla, California.
European Society of Gene & Cell Therapy (EGSCT) 25th Anniversary Congress, October 17 - 20, 2017, at the BCC Berlin in Berlin, Germany.
4th Animal Models of Neurodegenerative Disease Conference, October 22 - 24, 2017, at Chateau Liblice, Czech Republic.
About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases. www.uniQure.com
uniQure Contacts:
Maria E. Cantor | Eva M. Mulder | Tom Malone | |
Direct: 339-970-7536 | Direct: +31 20 240 6103 | Direct: 339-970-7558 | |
Mobile: 617-680-9452 | Mobile: +31 6 52 33 15 79 | Mobile: 339-223-8541 | |
m.cantor@uniQure.com | e.mulder@uniQure.com | t.malone@uniQure.com |
1 Year uniQure NV Chart |
1 Month uniQure NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions